Yantai Zhenghai Bio-tech, a Chinese biotechnology company backed by CDH Investments, saw its stock gain 44.03% on its first day of trading following a RMB234 million ($34 million) IPO in Shenzhen.
Zhenghai Bio-tech sold 20 million shares at RMB11.72 apiece. CDH - which invested $233,333 for a 12% stake in the company in 2015 - did not make a partial exit in the offering. The stock opened at RMB15.47...
Investors appear to be discounting Asia risk in the face of rising political concerns, ranging from North Korea to Myanmar
Chinese electric vehicle maker CHJ Automotive has completed a RMB3 billion ($474 million) Series B round led by Matrix Partners China and Shougang Fund, an investment firm backed by state-owned steel producer Shougang Corporation.
Naspers has sold a small portion of its stake in Tencent Holdings – the Chinese internet giant in which it acquired an approximately one-third stake for $32 million 16 years ago – for HK$76.9 billion ($9.8 billion).
Shunwei Capital has led a $25 million Series B round for ScaleFlux, a hardware firm based in the US and China.